318 results
8-K
EX-5.1
BMY
Bristol-Myers Squibb Co.
22 Feb 24
Other Events
4:15pm
having made any special investigation as to the applicability of another statute, law, rule or regulation. None of the opinions or other advice contained
8-K
EX-1.1
BMY
Bristol-Myers Squibb Co.
22 Feb 24
Other Events
4:15pm
of any claim under any environmental laws and the Company is not aware of any pending investigation that could reasonably be expected to lead … by such indemnified party, in connection with the defense thereof other than reasonable costs of investigation. Notwithstanding the foregoing
424B5
BMY
Bristol-Myers Squibb Co.
16 Feb 24
Prospectus supplement for primary offering
4:34pm
on our experience in the industry and our own investigation of market conditions. We believe these estimates to be accurate as of the date
424B2
px5nk8ro4 uud6xj
13 Feb 24
Prospectus for primary offering
8:00am
SC TO-T
EX-99
yq4rra grcn
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
0jp6y 7d1wofjoqigm4f
25 Jan 24
Third party tender offer statement
8:13am
8-K
EX-1.1
ajo2drvb
13 Nov 23
Other Events
4:19pm
8-K
EX-5.1
ev5j6hga0au
13 Nov 23
Other Events
4:19pm
424B5
qxdeh1bqm
1 Nov 23
Prospectus supplement for primary offering
4:16pm
424B3
ntuc5dgh3m owflgvh
30 Oct 23
Prospectus supplement
8:05am
DEFA14A
akf i2cat6a7pao
10 Apr 23
Additional proxy soliciting materials
5:12pm